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I am a surgeon and not a health-care administra-
tor. Consequently, when I was asked to address this
topic at recent national meetings, I turned to other
experts for information and advice. Specifically, the
following comments are based on information I
received from the Office of Strategic Planning and
Managed Care at the Mayo Clinic and from several
articles that summarize the rapid changes that are
occurring in surgical practice.1-6
Several questions were posed to me. What is
managed care? How is it being incorporated in the
present-day practice of medicine and surgery? Is
managed care working, and is it here to stay? What
does the future of vascular surgery look like in a
managed care environment? Some experts may find
the following answers to be simplistic. However, I
have tried to distill a complex health care environ-
ment into fundamental concepts and changes that
affect vascular surgeons.
THE ORIGINS OF MANAGED CARE
In the late 1920s, multispecialty medical prac-
tices were organized to provide contracted care for
employees of larger companies. Although this con-
cept was successful in some areas of the country,
most patients in America continued to seek medical
care from solo practitioners and smaller clinics where
a fee-for-service was paid (Fig. 1).
In the subsequent five decades, health care
expenditures in America escalated dramatically. In
the early 1970s, Paul Elwood and a group of health
care executives began to form the “Jackson Hole
Group,” who evolved the concept of health mainte-
nance organizations (HMOs).2 In late 1973,
Congress legislated federal funding for the organiza-
tion of HMOs. In most HMOs, the patient paid a
premium that was calculated to cover any health care
needed during the year. HMOs attempted to con-
tain costs by providing basic care but limiting access
to specialty care and high-technology testing and
treatments. In addition, the patient was generally
assigned to a physician and consequently lost some
freedom of choice (Fig. 2). However, HMO plans
did not adequately curtail rising health care costs.
In 1978, Alain Enthoven and others introduced
the concept of managed competition.1-2 In l992 this
concept became the cornerstone of the health care
reform program introduced by President Bill
Clinton, although key elements of the idea had been
proposed previously by the Bush administration.
Managed competition was based on the assumption
that economic incentives determine how patients,
payers, and providers behave when they seek, finance,
and render medical care. If incentives are altered and
people are made to bear the economic consequences
of their choices, health care reform will follow. In
particular, corporate America anticipated that man-
aged competition would reduce health care costs. Big
business believed that health care costs needed
urgent control because an increasing portion of their
overhead was health care for employees.
BUILDING BLOCKS OF MANAGED CARE
Managed competition has evolved to a concept
known currently as managed care.3-4 Four essential
building blocks should be emphasized: (1) capitated
payment for services (Fig. 3); (2) intensified preven-
tive services; (3) better patient education; and (4)
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Fig. 1. The traditional fee-for-service reimbursement has
escalated health care costs and has not controlled the clin-
ical outcome.
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clinical guidelines to reduce costly procedures of lit-
tle benefit. Although managed care has begun to
reduce total national health care expenditures, the
impact has not been as great as anticipated. For
example, national health care spending between
1980 and 1995 has quadrupled from $250 billion
per year to nearly $1 trillion per year.
WHAT IS THE PROBLEM?
In a recent editorial in the New England Journal
of Medicine,4 Eli Ginzberg and Mariam Ostow stat-
ed emphatically,
“Public concern, discontent, and distrust have
grown as enrollees have become increasingly aware
of the more egregious profit-oriented practices of
their managed care plans—providing bonuses to
physicians who cut back on referrals to specialists,
arbitrarily discharging physicians thought to use too
many resources, and deliberately delaying the
authorization of costly treatments without which
the patient’s health, and in some cases survival, may
be compromised.”
In an accompanying editorial, Jerome P.
Kassirer, editor of the journal, added, “I believe
that the homogenized one-model-fits-all, gate-
keeper-controlled approach to health care is a
failed experiment.”3
In some for-profit health maintenance organiza-
tions, 20 to 30 cents of each premium dollar is set
aside as profit. In dramatic contrast, not-for-profit
HMOs spend 97% of each health care dollar on
medical care, with a net operating income of approx-
imately 3%. In a recent study, the cost for care in a
for-profit HMO was higher in every category than
for enrollees of not-for-profit HMOs. For example,
the following differences were seen in yearly costs
per enrollee per year for for-profit versus not-for-
profit HMOs: In-patient day ($538 vs $495), ambu-
latory cost ($364 vs $330), and revenues per
enrollee ($695 vs $654).
Although not-for-profit HMOs appear to be a
better means of containing costs, a recent study from
Minnesota’s three largest HMOs revealed that they
had lost $71.5 million in 1996.6 “The real issue is no
longer cost,” said George Halvorson, Chief Executive
Officer of HealthPartners. “It is premiums.” In this
statement he admits that costs have been “cut to the
bone” in many medical centers without securing a
better profit or net operating income. Consequently,
other models for health care are being considered at
both a state and national level.
PURCHASING BUSINESS COOPERATIVES
One innovative option is a purchasing business
cooperative. What are its advantages in managing
health care for their employees? First, the coopera-
tive is self-insured by a group of businesses. Second,
there is a direct relationship of the business (buyer)
to the market (provider). In general, a modified fee-
for-service is negotiated. And finally, the patient can
choose their physician. For patients, this is an impor-
tant freedom of choice.
Fig. 2. The HMO era not only failed to control total national health care costs, but it also
limited patient choice.
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In Minnesota, 17 major businesses have orga-
nized to form the Business Health Care Action
Group, which combines nearly 300,000 patients.
This purchasing cooperative is designed to deal
directly with health care providers and eliminates
some of the administrative costs that went previously
to insurance “middlemen.” In the Minneapolis/St.
Paul area, the cities have been divided into 13 care
systems. Ninety-five percent of physicians in these
areas have signed with one of these care systems and
have indicated a willingness to work directly with the
purchasing cooperative.
When businesses were dealing through insurance
companies, the overhead was approximately 12% to
15% per health care premium dollar. In dealing
directly with health care providers, business purchas-
ing cooperatives have been able to bring overhead
costs per dollar to the 6% range. Will such savings
encourage the future penetration of business pur-
chasing cooperatives? In a recent analysis by the
Advisory Board to Smith Barney Associates, it was
speculated that the current 10% penetration of the
employee work force in Minnesota would rise to
approximately 30% by 2000 (Fig. 4).
GOVERNMENT MANAGED CARE
ACTIVITY
Today the largest purchaser of managed care in
the United States is the Health Care Financing
Administration (HCFA). Currently, there are approx-
imately 4.5 million Medicare patients in managed
care. In addition, 11.6 million Medicaid patients are
in some type of managed care system. In 14 states,
Medicare has demonstration projects that are
attempting to ascertain how to provide the best qual-
ity at lowest cost for such common and major tech-
nological therapies as coronary artery bypass grafting.
The HCFA is pushing toward more managed
care. Its strategists emphasize that three main factors
must be provided in managed care plans for Medicare
and Medicaid patients: (1) all plans must provide spe-
cialty coverage; (2) all patients must have access to fed-
erally approved drugs; and (3) patients with special
needs (e.g., vascular disease) will be permitted to select
a specialist as their primary care provider.
What is the anticipated Medicare risk product
enrollment in managed care plans for the future? In
1990 approximately 1.3 million patients were
enrolled. By 2005 it is anticipated that 40% of
Medicare patients will be under managed care (Fig.
5). Because nearly 70% to 80% of vascular surgical
patients are under Medicare, these changes will have
a major impact on all of us who care for patients with
peripheral vascular disease.
WHAT HAS MANAGED CARE ACHIEVED?
Although managed care has not been the
panacea for controlling health care costs, the con-
cept has resulted in several important changes in
American health care. These changes include: (1) a
focus on accountability and quality of care; (2) lower
hospitalization rates; (3) heavy investment in patient
information systems; (4) reduction in redundancy
and waste; (5) greater focus on disease prevention;
and (6) better management of chronic diseases.
If managed care is to survive, three other areas
must be assured for the future. The managed care
systems must care about more than profits. In addi-
tion, the systems cannot skimp on essential care,
especially for those with chronic illnesses. And final-
ly, the system must support education and research.
Currently, education and research dollars are being
threatened from every angle. Current attempts of
the Clinton administration to balance the federal
budget will result in substantial reductions in pay-
ment for graduate medical education. Survival of
academic medical centers is a real issue.
FUTURE MANAGED CARE CONTRACTS
Capitation encompasses the concept that a fixed
amount of money will be paid to the health care
provider for the management of a specific disease
process. If the health care provider is efficient in this
process, there will be an appropriate profit or net
operating income (Fig. 3). However, a miscalcula-
tion of cost or misuse of health care resources could
have a negative impact on the bottom line for the
health care provider.
Currently, managed care contracts fall under two
general types—global services and package services.
Managed contracts for global services allow access to
all services in a health system. The typical reim-
Fig. 3. Capitation provides a set or packaged fee for a sur-
gical service and expects not only to control cost but also
encourage good outcomes.
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bursement to the health care provider is discounted.
On the other hand, package services relate only to
selective high-dollar tertiary services. A fixed price
for the entire inpatient stay is provided. In addition,
extra money per day can be provided for outliers
who have a more complicated course.
What is the advantage of packaged fee services
for vascular surgeons? First, they allow the physician
the ability to manage the patient with “hands off”
from the purchaser. Second, such package services
emphasize the use of evidence-based practice guide-
lines to select patients for high-cost technologic pro-
cedures. Finally, package prices do mandate cost
control by the health care provider.
THE “MIXED MODEL” FOR THE FUTURE
Future health care systems will emphasize risk
sharing by the patient, the provider, and the payer.
The patient’s share in the risk of his or her health is
twofold: (1) disease prevention by healthier living
habits; and (2) health maintenance by periodic
checkups. In sharing risk, the provider must offer:
(1) appropriate access for care; (2) quality of care;
and (3) cost control. Finally, the payer must provide
appropriate administrative costs.
To achieve this risk sharing, several experts in
health care see the future system as a “mixed
model.” For a portion of the patients in a health care
system, a fee-for-service will persist. For other con-
ditions, managed care contracts may be more appro-
priate. Finally, the health care system must be flexi-
ble so that patients can move efficiently between
generalists and specialists.
Many academic medical centers are currently
developing regional health care systems that empha-
size the mixed model. Such Integrated Service
Networks generally encompass a geographic region.
In this region, the academic medical centers are
administratively and financially linked to outlying
smaller clinics and hospitals. The academic medical
centers provide administrative expertise to the mem-
bers of their health care system. In addition, special-
ists from academic medical centers often participate
in “outreach” programs at local community clinics
and hospitals. In return for capital and administra-
tive investments in the geographic area, the academ-
ic medical center shares in some way with the net
operating incomes of its members. In addition, such
health care systems encourage patients to move
toward the central academic medical centers for spe-
cialized problems that cannot be easily handled in
smaller facilities.
SUMMARY
Recently, William W. McGuire, Chief Executive
Officer of United Health-Care, emphasized that the
key from the patient’s viewpoint is access.5 He stat-
ed, “We use the term gateway rather than gatekeep-
er.” He emphasizes the importance of direct access
of the patient to the right physician, whether it be a
specialist or a generalist. Although some health care
strategists believe that patients should initially see a
Fig. 4. The current and anticipated penetration of health care market by business purchasing
cooperatives.
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generalist before receiving specialty care, this
approach may not save dollars in the long run.
Managed care is likely to have a major impact on
vascular surgeons. Currently, business purchasing
cooperatives are one model for containing costs of
expensive invasive procedures among the working
population. Such cooperatives are likely to achieve a
stronger penetration in the health care market and
to negotiate aggressively for packaged fee contracts
for specialized cardiovascular care and procedures.
Because the vast majority of vascular patients are
more than 65 years of age, the movement of
Medicare toward managed care may also affect vas-
cular surgery in a major way. If vascular surgeons are
to survive financially in the managed care environ-
ment, they must continue to provide evidence-based
solutions to clinical problems at a reasonable cost
and with good outcomes. They must also under-
stand that involvement in the administrative and
political leadership of health care is essential to main-
taining some influence on the future reimbursement
for our services.
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Fig. 5. Projected future enrollment of Medicare beneficiaries in managed care plans.
